首页> 外国专利> Use of fluorescein derivatives for the treatment of diseases responsive to the activation of the cystic fibrosis transmembrane conductance regulator chloride channel

Use of fluorescein derivatives for the treatment of diseases responsive to the activation of the cystic fibrosis transmembrane conductance regulator chloride channel

机译：荧光素衍生物在治疗对囊性纤维化，跨膜电导调节剂氯离子通道活化反应敏感的疾病中的用途

页面导航

摘要
著录项
相似文献

摘要

Fluorescein and derivatives have use in the treatment of a disease of a living animal body, including human, which disease is responsive to the inhibition of the cystic fibrosis transmembrane conductance regulator chloride channels, for instance polycystic kidney disease and secretory diarrhoea.

机译：荧光素及其衍生物已用于治疗包括人在内的活体动物的疾病，该疾病对囊性纤维化跨膜电导调节剂氯离子通道的抑制有反应，例如多囊性肾病和分泌性腹泻。

著录项

公开/公告号AU2001270809B2

专利类型
公开/公告日2006-04-13

原文格式PDF
申请/专利权人 UNIVERSITY OF BRISTOL;
展开▼

申请/专利号AU20010270809
发明设计人 DAVID NOEL SHEPPARD;ZHIWEI CAI;
展开▼

申请日2001-07-12
分类号A61K31;C07D311/84;A61K31/352;A61P1/12;A61P1/18;A61P5/48;A61P9/06;A61P13/12;A61P15/16;A61P35;A61P43;
国家 AU
入库时间 2022-08-21 21:34:41

相似文献

专利
外文文献
中文文献